Dyadic International DYAI
NASDAQ DYAI
$0.51 0.00 (-0.31%)
As of: Sep 10, 2026 · 1:27 PM EDT

Dyadic International (DYAI) Operating Expenses (2018 - 2026)

Dyadic International's (DYAI) quarterly Operating Expenses came in at $3.0 million in Q1 2026, up 25.78% year-over-year from $2.4 million in Q1 2025, and up 43.41% quarter-over-quarter from $2.1 million in Q4 2025.

Analysis

Dyadic International (DYAI) Operating Expenses (2018 - 2026) Analysis & Trends

Dyadic International has disclosed Operating Expenses across 9 years of filings, most recently posting $3.0 million for Q1 2026.

  • In Q1 2026, Operating Expenses rose 25.78% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $10.9 million (up 16.81% YoY), while the FY2025 annual figure was $10.3 million, up 9.44% from the prior year.
  • Operating Expenses came in at $3.0 million for Q1 2026 at Dyadic International, up from $2.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $4.0 million in Q2 2022 to a low of $2.1 million in Q4 2025.
  • Average Operating Expenses over 5 years is $2.8 million, with a median of $2.7 million recorded in 2022.
  • Year-over-year, Operating Expenses tumbled 99.91% in 2022 and surged 43.05% in 2025.
  • Over 5 years, Operating Expenses stood at $3.0 million in 2022, then dropped by 4.29% to $2.9 million in 2023, then slipped by 17.78% to $2.3 million in 2024, then decreased by 10.48% to $2.1 million in 2025, then soared by 43.41% to $3.0 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $3.0 million in Q1 2026, $2.1 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.84 Bn 192.85 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 180.29 Bn 177.11 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 131.27 Bn 123.42 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.95 Bn 73.96 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.32 Bn 55.13 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.94 Bn 48.80 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.35 Bn 30.04 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.85 Bn 30.56 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.08 Bn 29.08 Bn 1.16 Mn 367.83 Mn
10 Dyadic International 18.44 Mn 10.48 Mn - 3.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.01 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 2.70 Mn
Mar 31, 2025 2.40 Mn
Dec 31, 2024 2.35 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 2.43 Mn
Mar 31, 2024 2.46 Mn
Dec 31, 2023 2.86 Mn
Sep 30, 2023 2.12 Mn
Jun 30, 2023 3.13 Mn
Mar 31, 2023 3.03 Mn
Dec 31, 2022 2.98 Mn
Sep 30, 2022 2.74 Mn
Jun 30, 2022 3.98 Mn
Mar 31, 2022 3.39 Mn
Dec 31, 2021 4.53 Mn
Sep 30, 2021 4.02 Mn
Jun 30, 2021 4.80 Mn